FDA Approves Psoriatic Arthritis Drug For Chrohn’s Disease
Related Arthritis Articles
The popular drug Humira which is currently used to treat Psoriatic Arthritis was approved on Feb. 27 by the FDA to treat adult Chrohn’s disease. According to the National Digestive Disease Information Clearinghouse (NDDIC), “Chrones Disease Crohn’s disease is an inflammatory bowel disease, the general name for diseases that cause swelling in the intestines. Crohn’s disease can affect any area of the GI tract, from the mouth to the anus, but it most commonly affects the lower part of the small intestine, called the ileum. The swelling extends deep into the lining of the affected organ. The swelling can cause pain and can make the intestines empty frequently, resulting in diarrhea.” Chrohn’s disease afflicts around 500,000 people in the United States. Symptoms experienced by those with the disease include abdominal cramps, persistent diarrhea, fever, pain, and fatigue. According to the FDA, “Humira works to reduce levels of human tumor necrosis factor (TNF) alpha, a chemical that plays a role in abnormal responses from the body's immune system.” Most people infected with the disease are diagnosed between the ages of 15 and 35. Some of the side affects of Humira include serious risk of infection such as tuberculosis or blood infections. Less severe side affects include upper respiratory infections, sinusitis, and nausea. Humira was approved originally by the FDA to treat Psoriatic Arthritis in October of 2005 and was later approved to treat moderate-to-severe rheumatoid arthritis. Visit this Consumer Advocacy website for more information on ordering from an online Mexican pharmacy.
Mark has been in the pharmaceutical search industry since 1999 and has quickly become one of the most widely used pharmaceutical resource sites. Visit this Consumer Advocacy website for more information on ordering from <a href="http://www.premiermexicanpharmacies.com">Mexican pharmacies</a>.
Disclaimer: The information presented and opinions expressed herein are those of the authors and do not necessarily represent the views of ArticlePros.com and/or its partners.
